Drugs / Oral poliovirus vaccine (OPV)
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01171963 | Aug 2010 → May 2012 | Rotavirus infection | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Oral poliovirus vaccine (OPV) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01171963 ↗ |
| Modality | Vaccine | “3 doses of the oral poliovirus vaccine manufactured by the Institute of Medical Biology of the Chinese Academy of Medical Sciences (OPV)” NCT01171963 ↗ |
| Route | Oral | “The Rotarix™ and OPV vaccines were administered orally” NCT01171963 ↗ |